Transdermal delivery of GLP-1 medications faces significant challenges due to the large molecular size of GLP-1 analogs and the skin's natural barrier function
Below, we break down why tracking matters, what to look for in an app, and how Pep brings dose logging, side-effect monitoring, nutrition, and progress into one place
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
Saxenda (liraglutide) product information
However, a low-calorie diet along with GLP-1 agonist drugs can also lead to loss of lean mass, emphasizing the need for protein intake with resistance training to preserve muscle mass
Medical education initiatives enhance physician training in obesity pharmacotherapy management and patient selection criteria